Besonderhede van voorbeeld: -4234624392371100212

English

In the interim, novel approaches to the use of licensed drugs including monotherapy with ritonavir-boosted PI, NRTI-sparing strategies or antiretroviral deferral strategies i.e. using recombinant interleukin-2 (40 ), must only be explored in the setting of properly designed, randomised, clinical trials in order to determine their place in the management of initial treatment of HIV infection.

Chinese

目前为止,使用获批药物的新途径包括使用利托那韦增强 的 PI 单药治疗、不含 NRTI 的策略或推迟抗反转录病毒治疗策略(即使用重组白介素 2 ) ( 40 ) , 都必须在设计合理、随机设置的临床试验中进行研究,以确定其在 HIV 感染初次治疗管理 中的作用。